Page 1518 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1518

Chapter 107







                     REFERENCES

                       1. Sharma P, Rakela J. Management of pre-liver transplantation     15. Schmidt GA. Management of the patient with cirrhosis. In: Hall
                        patient—part 2. Liver Transpl. 2005;11(3):249-260.      JB, Schmidt GA, Wood LDH, eds.  Principles of Critical Care.
                       2. Garcia-Tsao  G.  Portal  hypertension.  Curr Opin Gastroenterol.   New York, NY: McGraw-Hill; 2005:1289-1298.
                        2006;22(3):254-262.                                  16. Ramsay MA. Portopulmonary hypertension and hepatopulmo-
                       3. Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol   nary syndrome, and liver transplantation. Int Anesthesiol Clin.
                        Hepatol. 2001;13(4):325-334.                            2006;44(3):69-82.
                       4. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update     17. Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale
                        of pathophysiologic mechanisms.  Proc Soc Exp Biol Med.   of two circulations. Chest. 2003;123(2):562-576.
                        1999;222(2):99-112.                                  18. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemody-
                       5. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—   namics and perioperative cardiopulmonary-related mortality in
                        definition, nomenclature, diagnosis, and quantification: final   patients with portopulmonary hypertension undergoing liver
                        report of the working party at the 11th World Congresses of   transplantation. Liver Transpl. 2000;6(4):443-450.
                        Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716-721.    19. Krowka MJ, Frantz RP, McGoon MD, et al. Improvement in
                       6. Han MK, Hyzy R. Advances in critical care management of   pulmonary hemodynamics during intravenous epoprostenol
                        hepatic failure and insufficiency. Crit Care Med. 2006;34(suppl   (prostacyclin): a study of 15 patients with moderate to severe
                        9):S225-S231.                                           portopulmonary hypertension. Hepatology. 1999;30(3):641-648.
                       7. Murphy N. Diagnosis and management of liver failure in     20. Chua R, Keogh A, Miyashita M. Novel use of sildenafil in
                        the adult. In Parrillo JE, Dellinger RP, eds.  Critical Care   the treatment of portopulmonary hypertension.  J Heart Lung
                        Medicine: Principles of Diagnosis and Management in the Adult.   Transplant. 2005;24(4):498-500.
                        Philadelphia, PA: Mosby Elsevier; 2008:1575-1604.    21. Garcia N Jr, Mihas AA. Hepatic hydrothorax: pathophysiology,
                                                                                diagnosis, and management. J Clin Gastroenterol. 2004;38(1):52-58.
                       8. Lawrence KR, Klee JA. Rifaximin for the treatment of hepatic
                        encephalopathy. Pharmacotherapy. 2008;28(8):1019-1032.    22. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax.  Curr  Opin
                                                                                Pulm Med. 2003;9(4):261-265.
                       9. Wong F, Girgrah N, Graba J, et al. The cardiac response to exer-
                        cise in cirrhosis. Gut. 2001;49(2):268-275.          23. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention
                                                                                and treatment of hepatorenal syndrome in cirrhosis.  Gut.
                      10. Canabal JM, Kramer DJ. Management of sepsis in patients with
                        liver failure. Curr Opin Crit Care. 2008;14(2):189-197.  2007;56(9):1310-1318.
                                                                             24. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic
                      11. TenHoor  T,  Mannino  DM,  Moss  M.  Risk  factors  for  ARDS
                        in the United States: analysis of the 1993 National Mortality   criteria of refractory ascites and hepatorenal syndrome in cirrho-
                        Followback Study. Chest. 2001;119(4):1179-1184.         sis. International Ascites Club. Hepatology. 1996;23(1):164-176.
                                                                             25. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospec-
                      12. International consensus conferences in intensive care medicine:   tive, double-blind, placebo-controlled trial of terlipressin for type 1
                        ventilator-associated Lung Injury in ARDS. This official confer-  hepatorenal syndrome. Gastroenterology. 2008;134(5):1360-1368.
                        ence report was cosponsored by the American Thoracic Society,
                        The European Society of Intensive Care Medicine, and The     26. Runyon BA. Management of adult patients with ascites due to
                        Societe de Reanimation de Langue Francaise, and was approved   cirrhosis: an update. Hepatology. 2009;49(6):2087-2107.
                        by the ATS Board of Directors, July 1999. Am J Respir Crit Care     27. Sigal SH, Stanca CM, Fernandez J, et al. Restricted use of albumin
                        Med. 1999;160(6):2118-2124.                             for spontaneous bacterial peritonitis. Gut. 2007;56(4):597-599.
                      13. Ventilation with lower tidal volumes as compared with tra-    28. Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin
                        ditional tidal volumes for acute lung injury and the  acute   and albumin vs albumin in patients with cirrhosis and hepa-
                        respiratory distress syndrome. The Acute Respiratory Distress   torenal syndrome: a randomized study.  Gastroenterology.
                        Syndrome Network. N Engl J Med. 2000;342(18):1301-1308.  2008;134(5):1352-1359.
                      14. Martinez GP, Barbera JA, Visa J, et al. Hepatopulmonary     29. Chava SP, Singh B, Zaman MB, et al. Current indications for
                        syndrome in candidates for liver transplantation.  J Hepatol.   combined liver and kidney transplantation in adults. Transplant
                        2001;34(5):651-657.                                     Rev (Orlando). 2009;23(2):111-119.







            Section09-O-Ref.indd   1                                                                                   12/10/2014   6:09:25 PM
   1513   1514   1515   1516   1517   1518   1519   1520   1521   1522   1523